| Website | eurogentec.com |
| Category | BioTech |
| info@eurogentec.com | |
| Employees | 400 |
| Founded | 1985 |
| Description | Experience True Partnership |
| AnaSpec, 10/09 |
Eurogentec is an international biotechnology supplier, based in Belgium, who specialize in genomics and proteomics kits and reagents. The company was founded in 1985 as a spin-off from the University of Liège. Eurogentec is also a contract manufacturing organization, licensed by the Belgian ministry of health to manufacture biologics.
It operates two manufacturing facilities in Belgium that provide custom biologics and oligonucleotide-based components for diagnostic and therapeutic applications.
Eurogentec has developed three interrelated business units, Life Science Research Products and Services, Molecular Diagnostics Manufacturing Solutions, and GMP BioManufacturing.
The life science business unit specializes in Genomics (e.g. Oligonucleotides, DNA polymerases, Real-time qPCR Probes and High-throughput Dispensing) and Proteomics (e.g. monoclonal and polyclonal antibodies, peptides, assay kits and fluorescent dyes).
The diagnostics business unit provides products for DNA- and RNA-based molecular diagnostics assay; manufacturing processes take place in clean rooms.
The biomanufacturing business unit is a GMP Biomanufacturer specialized in the technology transfer, process development, scale-up and manufacturing of proteins, plasmids and vaccines. In 2009, Eurogentec Biologics developed a vaccine against bilharziosis in partnership with INSERM and researchers from the Pasteur Institute.
